Member of Congress Highlights Lack of Regulation of Potentially Dangerous Flu Research
Rep. Sensenbrenner spotlights controversial avian flu studies.
FDA Warns Patients of Stem Cell Scams
The FDA cautions patients to undergo only approved stem cell treatments.
Regulatory Conference Discusses Oversight of Laboratory Developed Tests
Regulatory conference highlights need for defined governance of laboratory developed diagnostic testing.
FDA and NABP Mobilize to Confront the Online Sale of Illegal Drugs
Governmental and nongovernmental action taken to discourage illegal pharmaceutical sales over the Internet.
Petition Calls for Reform of FDA Regulation of Generic Drug Labels
Advocacy group petitions agency to let generic drug manufacturers update labels.
House Hearing on Efforts to Confront Alzheimer’s Disease
Hearing discusses how to address potential global crisis.
Senate Hearing on Diabetes Urges Development of Artificial Pancreas
Committee members urge FDA to expedite releasing industry guidance.
House Passes Bill to Ban Indirect Federal Funding of Abortion
The bill would prohibit government subsidies for healthcare plans that cover abortions.
FDA Grants Hearing on Proposed Withdrawal of Marketing Approval for Avastin
The FDA proposes to withdraw approval for a breast cancer treatment, with hearing scheduled for June.
Ongoing Litigation in Human Embryonic Stem Cell Research
Lawsuits over stem cell research could alter current scientific approaches.